Baxa Corporation Signs Co-Marketing Agreement with VIASYS MedSystems for Specialty Enteral Feeding Products
18 Gennaio 2007 - 3:00PM
PR Newswire (US)
ENGLEWOOD, Colo., Jan. 18 /PRNewswire/ -- Baxa Corporation has
signed an exclusive co-marketing agreement with VIASYS MedSystems
Inc., a subsidiary of VIASYS Healthcare Inc. (NYSE:VAS) to
cross-promote their respective enteral feeding products for
neonates. The agreement covers the Baxa Exacta-Med(R) Enteral
Syringes and the VIASYS CORFLO(R) Anti-IV Enteral Feeding System,
which combine to form a system intended to reduce the wrong-route
administration of non-IV fluids for neonatal and pediatric
patients. The first syringes designed only for enteral feeding,
Baxa Exacta-Med Enteral Syringes are available individually
packaged in 20, 35 and 60 mL sizes. The syringes feature a unique
tip that cannot connect to a luer needle or needleless IV system.
Unique coloring and markings make them the safer choice for enteral
fluid drug delivery, particularly in pediatric and neonatal
applications where the majority of the oral and enteral doses are
provided through a gastric tube. The CORFLO Anti-IV Enteral Feeding
System promotes safe, non-luer connections for enteral feeding of
neonatal and pediatric patients. The system's non-luer connections
are designed to accept only a dedicated enteral syringe tip. In
addition to the Anti-IV System, VIASYS MedSystems provides a
complete range of enteral access devices to fit specific clinical
needs in the hospital, nursing home, and home care markets. "The
agreement," notes Baxa Product Manager Katie Calabrese, "formalizes
the strong relationship that Baxa and VIASYS have built over the
past few months in addressing the issue of tubing misconnections in
our most critical patients -- neonates. Both companies are focused
on developing a safe alternative to current practice that reduces
wrong-route errors. Together, we can offer a complete, dedicated
system." Baxa Corporation focuses on providing technology to
health-system pharmacies that improves patient safety, reduces the
risk of medication errors and facilitates compliance to USP, JCAHO
and other regulatory requirements. Baxa introduced the Enteral
Syringes at the American Society of Health-System Pharmacists
(ASHP) Midyear Clinical Meeting held December 3-8, 2006, in
Anaheim, California. About Baxa Corporation Baxa, a
customer-focused medical device company, provides innovative,
solution-based technologies for fluid handling and delivery. Its
systems and devices promote the safe and efficient preparation,
handling, packaging, and administration of fluid medications.
Privately held, Baxa Corporation has subsidiaries and sales offices
in Canada and the United Kingdom; direct representation in Austria,
Belgium, Denmark, Finland, France, Germany, Luxembourg and The
Netherlands; and distribution partners worldwide. Further
information is available at http://www.baxa.com/. About VIASYS
Healthcare Inc. VIASYS Healthcare Inc. is a global, research-based
medical technology company focused on respiratory, neurology,
medical disposable and orthopedic products. VIASYS products are
marketed under well-recognized trademarks including, among others,
AVEA(R), BEAR(R), BIRD(R), CORFLO(R), CORPAK(R), CORTRAK(R),
EME(R), GRASON-STADLER(R), JAEGER(TM), LYRA(R), MEDELEC(R),
MICROGAS(R), NAVIGATOR(R), NICOLET(R), NicoletOne(TM),
PULMONETIC(TM), SENSORMEDICS(R), TECA(R), TECOMET(TM), VELA(R) and
VMAX(R). VIASYS is headquartered in Conshohocken, PA, and its
businesses are conducted through its Respiratory Care, NeuroCare,
MedSystems and Orthopedics business units. More information can be
found at http://www.viasyshealthcare.com/. Contact: Marian
Robinson, Vice President, Marketing Baxa Corporation: 800.567.2292
ext. 2157 or 303.617.2157 Email: Maggie Chamberlin Holben, APR
Absolutely Public Relations: 303.984.9801 or 303.669.3558 Email:
DATASOURCE: Baxa Corporation CONTACT: Marian Robinson, Vice
President, Marketing of Baxa Corporation, 800-567-2292, ext. 2157,
or +1-303-617-2157, or ; or Maggie Chamberlin Holben of Absolutely
Public Relations, +1-303-984-9801, or +1-303-669-3558, or , for
Baxa Corporation Web site: http://www.baxa.com/
http://www.viasyshealthcare.com/
Copyright
Grafico Azioni Viasys Healthcare (NYSE:VAS)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Viasys Healthcare (NYSE:VAS)
Storico
Da Mag 2023 a Mag 2024